TNF Pharmaceuticals (TNFA) versus Its Competitors Critical Survey
Volatility & Risk TNF Pharmaceuticals has a beta of 2.13, suggesting that its share price is 113% more volatile than the S&P 500. Comparatively, TNF Pharmaceuticals’ rivals have a beta of 1.29, suggesting that their average share price is 29% more volatile than the S&P 500. Insider & Institutional Ownership 9.6% of TNF Pharmaceuticals shares […]
Volatility & Risk TNF Pharmaceuticals has a beta of 2.13, suggesting that its share price is 113% more volatile than the S&P 500. Comparatively, TNF Pharmaceuticals’ rivals have a beta of 1.29, suggesting that their average share price is 29% more volatile than the S&P 500. Insider & Institutional Ownership 9.6% of TNF Pharmaceuticals shares […]
